NEWS

  • Kantum Pharma Highlights New Research Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury

    May 27, 2020

    CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ -- Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused on developing therapies for the prevention and treatment of damaging inflammation trigge...

    Read More
  • FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

    May 5, 2020

    Bordeaux, May 5, 2020 – FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS),...

    Read More
  • Acesion Pharma Strengthens Clinical Team with Key Appointments

    May 7, 2020

    Copenhagen, 5 May 2020. Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac arrhythmia, today announced that it has recru...

    Read More
  • AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

    April 28, 2020

    April 28, 2020 SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, in...

    Read More
  • CroíValve announces successful first human use of its Duo Tricuspid Coaptation Valve technology

    March 23, 2020

    Dublin, Ireland, 23 March 2020 - CroíValve announced today the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The procedure was performed by an expe...

    Read More
  • Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board

    February 24, 2020

    Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-based treatments for cardiovascular disease, tod...

    Read More
  • Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

    February 6, 2020

    February 06, 2020 07:00 AM Eastern Standard Time SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced tha...

    Read More
  • Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China

    November 5, 2019

    November 5, 2019 3:30pm Eastern Daylight Time NEW HAVEN, Conn. and NANJING, China, (PRNewswire.com) - Simcere Pharmaceutical Group and Aeromics, Inc. today announce collaboration and exclusive lice...

    Read More
  • Kantum Pharma Founder to Present Preclinical Data Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting

    November 4, 2019

    November 4, 2019 3:30pm Eastern Daylight Time CAMBRIDGE, MA (Newswire.com) - ​Kantum Pharma Inc., a biopharmaceutical company focused on developing therapies for the prevention and treatment of d...

    Read More
  • CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials

    September 12, 2019

    September 12, 2019 07:00 AM Eastern Daylight Time DUBLIN (BUSINESS WIRE)– €4 million in additional financing has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterp...

    Read More